Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • One-step TUNEL Cy3 Apoptosis Detection Kit: Precision DNA...

    2025-11-20

    One-step TUNEL Cy3 Apoptosis Detection Kit: Precision DNA Fragmentation Assay

    Executive Summary: The One-step TUNEL Cy3 Apoptosis Detection Kit (K1134) by APExBIO enables fluorescent detection of DNA fragmentation, the hallmark of apoptosis, using Cy3-labeled dUTP and terminal deoxynucleotidyl transferase (TdT) for a one-step workflow (Theranostics, 2025). Its performance is validated in both tissue sections and cultured cells, including 293A cells treated with DNase I or camptothecin. The kit's excitation/emission maxima (550/570 nm) allow for compatibility with standard fluorescence microscopy and flow cytometry platforms. Optimized component stability (up to one year at -20°C, protected from light) ensures reproducibility and reliability in apoptosis research (APExBIO product page, last accessed 2024-06). The K1134 kit is for research use only and is not suitable for diagnostic or therapeutic applications.

    Biological Rationale

    Apoptosis is a form of programmed cell death characterized by specific morphological and biochemical features, including DNA fragmentation into oligonucleosomal units (180–200 bp) due to endonuclease activation (Theranostics, 2025). Detecting these DNA breaks is essential for differentiating apoptosis from other forms of cell death, such as necrosis or pyroptosis. The TUNEL (Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling) assay is a gold-standard method for labeling 3'-OH ends of fragmented DNA, enabling direct visualization and quantification of apoptotic cells (LBBroth Guide). The One-step TUNEL Cy3 Apoptosis Detection Kit delivers this functionality in a simplified format, supporting both tissue and cell-based applications and facilitating advanced studies in cancer, toxicology, and developmental biology.

    Mechanism of Action of One-step TUNEL Cy3 Apoptosis Detection Kit

    The One-step TUNEL Cy3 Apoptosis Detection Kit utilizes a single-step enzymatic reaction. Terminal deoxynucleotidyl transferase (TdT) catalyzes the incorporation of Cy3-labeled deoxyuridine triphosphate (dUTP) at the 3'-OH ends of DNA fragments, which are generated during apoptosis (APExBIO). Cy3 offers strong fluorescence with excitation at 550 nm and emission at 570 nm, allowing sensitive detection via standard fluorescence microscopy or flow cytometry. The reaction is performed in situ on fixed, permeabilized cells or tissue sections. The protocol is compatible with both paraffin-embedded and cryopreserved samples, as well as adherent and suspension cell cultures. The workflow minimizes sample handling and reduces potential artifactual DNA breakage, supporting high specificity for apoptotic DNA fragmentation.

    Evidence & Benchmarks

    • The K1134 kit reliably labels DNA nicks in apoptotic 293A cells induced by DNase I or camptothecin under standard conditions (Theranostics 2025, https://doi.org/10.7150/thno.102228).
    • Excitation/emission maxima of Cy3 (550/570 nm) ensure compatibility with most fluorescence microscopes and flow cytometers, supporting flexible imaging and quantitation (APExBIO).
    • Kit components, including the Cy3-dUTP Labeling Mix, remain stable for up to one year when stored at -20°C and protected from light (APExBIO).
    • The TUNEL assay mechanism is validated as specific for apoptotic DNA fragmentation versus necrosis or pyroptosis when combined with orthogonal markers (Tautomycetin Review).
    • The kit has been applied successfully to both paraffin-embedded and frozen tissue sections, expanding its versatility (Dimesna Article).

    Applications, Limits & Misconceptions

    The One-step TUNEL Cy3 Apoptosis Detection Kit is designed for research-only applications requiring sensitive detection of DNA fragmentation in apoptotic cells. It is used in oncology, developmental biology, neurobiology, and toxicology studies to quantify cell death in situ. The assay can be applied to both tissue sections (paraffin-embedded or frozen) and cultured cells (adherent or suspension), enabling broad experimental flexibility. By directly labeling 3'-OH DNA ends, it provides a quantitative readout of apoptosis at single-cell resolution (5-Methoxy-CTP Article), complementing flow cytometry or imaging-based quantification. This article expands upon previous guides by detailing validated sample types and highlighting the kit's robust performance in comparative apoptosis research. For a mechanistic perspective on differentiating apoptosis from pyroptosis and advanced quantification, see the LBBroth article; this page provides updated evidence benchmarks and workflow integration strategies.

    Common Pitfalls or Misconceptions

    • Non-apoptotic DNA breaks: The kit detects DNA nicks regardless of origin; thus, non-apoptotic DNA damage (e.g., necrosis, mechanical shearing) may yield false positives unless orthogonal apoptosis markers are used (Theranostics 2025).
    • Not for live-cell use: The assay requires fixation and permeabilization; it cannot be applied directly to living cells.
    • Not diagnostic: The kit is for research use only and is not validated for diagnostic or therapeutic decision-making (APExBIO).
    • Limited quantification in necrotic tissues: In tissues with extensive necrosis, background labeling may increase, requiring careful control experiments.
    • Signal stability: Cy3 fluorescence may fade under prolonged or intense illumination; samples should be protected from light during and after processing.

    Workflow Integration & Parameters

    The K1134 kit supports streamlined integration into standard cell biology and histology workflows. Key steps include fixation (e.g., 4% paraformaldehyde, 10–20 minutes at room temperature), permeabilization (e.g., 0.1–0.5% Triton X-100, 5–10 minutes), and incubation with the Cy3-dUTP/TdT mix (37°C, 30–60 minutes, protected from light). After washing, samples can be mounted and imaged directly or analyzed by flow cytometry. Positive controls (e.g., DNase I-treated samples) and negative controls (omission of TdT enzyme) are recommended for assay validation. The kit's single-step design reduces hands-on time and minimizes procedural variability. Component storage at -20°C ensures reagent stability for up to 12 months. For advanced quantification guidance and troubleshooting tips, see the comprehensive guide at dnase-i.com; this article extends that resource by providing updated performance metrics and evidence-based best practices.

    Conclusion & Outlook

    The One-step TUNEL Cy3 Apoptosis Detection Kit (K1134) from APExBIO is a validated tool for the rapid, quantitative detection of apoptotic DNA fragmentation in a wide range of research samples. Its optimized one-step protocol, bright Cy3 fluorescence, and robust sample compatibility establish it as a gold standard for apoptosis detection workflows. Ongoing advances in programmed cell death research, including the emerging interplay between apoptosis and pyroptosis (Theranostics 2025), underscore the importance of reliable TUNEL-based assays for dissecting complex cell death mechanisms. For further reading on the kit's integration into apoptosis–pyroptosis studies, see the in-depth review at tautomycetin.com; this article provides updated benchmarks and application boundaries to guide experimental planning.